Drug Trial Radar · NCT07112872
A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
330
Planned (sponsor's estimate)
Start
Aug 19, 2025
Primary completion
Feb 5, 2028
Study completion Feb 5, 2028
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Aug 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This multicenter, randomized, double-blind, placebo- and open-label active comparator-controlled, parallel-group, dose-range-finding, Phase II study aims to evaluate the efficacy, tolerability, and safety of different doses of tifeglipron for glycemic control in adult participants with Type 2 diabetes mellitus (T2D).
Conditions
- Type 2 Diabetes Mellitus
Interventions
TifeglipronDrug
Tifeglipron will be taken orally once daily (QD), according to the randomized dosing regimen, during the 30-week treatment period.
SemaglutideDrug
Semaglutide 14 mg will be taken orally QD, with up-titration as per label, during the 30-week treatment period.
PlaceboDrug
Placebo matching tifeglipron will be taken orally QD during the 30-week treatment period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Tifeglipron vs. Placebo: Change in Glycated Hemoglobin (HbA1c) from Baseline at Week 30Time frame: Baseline to Week 30
Locations
51 sites in 4 countries. Site status is shown where the registry gives one.
Arizona Liver Health - Tucson
Tucson, Arizona · Recruiting
Orange County Research Center
Lake Forest, California · Recruiting
Prospective Research Innovations Inc.
Rancho Cucamonga, California · Recruiting
Encompass Clinical Research
Spring Valley, California · Recruiting
Chase Medical Research
Waterbury, Connecticut · Recruiting
Emerson Clinical Research Institute
Washington D.C., District of Columbia · Recruiting
K2 Medical Research South Orlando, LLC
Clermont, Florida · Active not recruiting
Center for Diabetes, Obesity and Metabolism Inc
Pembroke Pines, Florida · Completed
Rophe Adult and Pediatric Medicine/SKYCRNG
Union City, Georgia · Active not recruiting
Accellacare of Duly Health and Care
Oak Lawn, Illinois · Active not recruiting
Mercury Street Medical Group, PLLC
Butte, Montana · Withdrawn
Neurobehavioral Research, Inc.
Cedarhurst, New York · Completed
Accellacare of Piedmont Healthcare
Statesville, North Carolina · Recruiting
Accellacare of Wilmington, LLC
Wilmington, North Carolina · Recruiting
NexGen Research
Lima, Ohio · Active not recruiting
Tristar Clinical Investigations
Philadelphia, Pennsylvania · Recruiting
Alliance for Multispecialty Research. LLC
Knoxville, Tennessee · Withdrawn
Clinical Research Associates
Nashville, Tennessee · Completed
Texas Diabetes & Endocrinology, P.A.
Austin, Texas · Completed
Apex Mobile Clinical Research
Bellaire, Texas · Active not recruiting
Velocity Clinical Research
Dallas, Texas · Completed
Velocity Clinical Research (Impact Research Institute)
Waco, Texas · Withdrawn
Chrysalis Clinical Research
St. George, Utah · Completed
Manassas Clinical Research Center
Manassas, Virginia · Recruiting
Obudai Egeszsegugyi Centrum Kft.
Budapest, Hungary · Completed
Qualiclinic Kft.
Budapest, Hungary · Withdrawn
Centrum Medyczne INTERCOR Sp. z o.o.
Bydgoszcz, Poland · Active not recruiting
Pro Familia Altera Sp z o.o.
Katowice, Poland · Active not recruiting
ETG Lublin
Lublin, Poland · Completed
Ekamed sp. z o.o.
Lublin, Poland · Completed
NZOZ METABOLICA Osrodek Badan Klinicznych
Tarnów, Poland · Active not recruiting
ETG Warszawa
Warsaw, Poland · Completed
Centrum Badan Klinicznych
Wroclaw, Poland · Active not recruiting
ETG Zamosc
Zamość, Poland · Active not recruiting
NZOZ Osteo-Medic s.c. A. Racewicz, J.Supronik
Bialystok, Podlaskie Voivodeship, Poland · Completed
Centrum Badan Klinicznych PI-House sp. z o.o.
Gdansk, Pomeranian Voivodeship, Poland · Active not recruiting
Centro Medico Teknon
Barcelona, Spain · Active not recruiting
Hospital Universitario Vall d'Hebron
Barcelona, Spain · Active not recruiting
Hospital Clinic de Barcelona (Hospital Clinic i Provincial)
Barcelona, Spain · Active not recruiting
Hospital General Universitario Gregorio Maranon (HGUGM)
Madrid, Spain · Active not recruiting
Showing 40 of 51 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.